step semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial How to Inject Semaglutide |
Description
Understanding your GLP1R, GIPR, MC4R, and FTO variants before starting treatment helps your clinician select the right medication and dose from day one, reducing the likelihood of plateau or weight regain later

Efficacy and safety of liraglutide and semaglutide on weight loss in people with obesity or overweight: A systematic review

This verification process ensures research reliability by eliminating variability that can affect experimental outcomes or data interpretation
Research shows that some weight loss from the medication involves muscle loss rather than fat loss

There is some logic to that
